HSCS

Heart Test Laboratories Inc. Common Stock

HSCS, USA

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

https://heartsciences.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HSCS
stock
HSCS

HeartSciences Inc. Announces Commercial Release of MyoVista Insightsâ„¢ Version 1.1 Enhancing ECG System Capabilities Quiver Quantitative

Read more →
HSCS
stock
HSCS

HeartSciences (Nasdaq: HSCS) rolls out MyoVista Insights 1.1 to enhance ECG workflows Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-07-31)

Rating:

STRONG BUY

Target Price:

$10.5

Analyst Picks

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-07-31)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.09

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-65.42 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.03 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-102,808.79 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.05

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 2.38% of the total shares of Heart Test Laboratories Inc. Common Stock

1.

Citadel Advisors Llc

(0.737%)

since

2025/06/30

2.

Geode Capital Management, LLC

(0.4575%)

since

2025/06/30

3.

Advisory Services Network, LLC

(0.3945%)

since

2025/06/30

4.

Fidelity Extended Market Index

(0.2281%)

since

2025/07/31

5.

Fidelity Total Market Index

(0.0887%)

since

2025/07/31

6.

Spartan Extended Market Index Pool F

(0.0878%)

since

2025/07/31

7.

NT Ext Equity Mkt Idx Fd - NL

(0.0652%)

since

2025/06/30

8.

Fidelity Series Total Market Index

(0.0529%)

since

2025/07/31

9.

Vanguard Institutional Extnd Mkt Idx Tr

(0.052%)

since

2025/07/31

10.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0506%)

since

2025/06/30

11.

NT Ext Equity Mkt Idx Fd - L

(0.0447%)

since

2025/06/30

12.

Northern Trust Extended Eq Market Idx

(0.0447%)

since

2025/06/30

13.

Tower Research Capital LLC

(0.0262%)

since

2025/06/30

15.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0126%)

since

2025/06/30

16.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0107%)

since

2024/12/31

17.

Spartan Total Market Index Pool G

(0.0086%)

since

2025/07/31

18.

Bank of America Corp

(0.0004%)

since

2025/06/30

19.

Advisor Group Holdings, Inc.

(0%)

since

2025/06/30

20.

UBS Group AG

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-07-31

EPS Actual

—

EPS Estimate

-1.875

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-07-31)

Deep Value
Potential Value Candidate(4)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(2.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(2)
Net Net
Strong Net-Net(6.5)
Quality
Low Quality Business(1.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-07-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-07-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-07-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.